Celregen Therapeutics
Latest round
- Angel
Last raised
- Mar 2025
Total raised
- $20M
Investors
- 2
About Celregen Therapeutics
Established in 2022 and based in Hangzhou, China, Celregen Therapeutics is a medical service provider dedicated to the research and development and clinical transformation of regenerative medicine products such as cornea and pancreatic islets. The company was incubated by the New Drug Innovation Fund of Fujian Capital. It has a research and development center in Shanghai. The company is committed to the innovation of stem cell regenerative medicine technology and the research and development of iPSC organ transplantation alternative products. Its products include the CRG-101 iPSC-derived corneal endothelial cell product pipeline and the CRG-002 iPSC-derived pancreatic islet cell pipeline. It has also established three iPSC regenerative medicine technology platforms, namely the CRG-iPSC somatic cell reprogramming platform, the CRG-EDIT gene editing platform, and the CRG-XDIF stem cell multidirectional differentiation platform. The company generates revenue by providing cornea, pancreatic islets, liver and gallbladder cell regeneration medicine products. The company will use the funds to build an iPSC regenerative medicine platform and promote clinical transformation in pipelines such as metabolism and ophthalmology.
Who invested in Celregen Therapeutics
2 investors across 3 rounds
See all investors in Celregen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celregen Therapeutics
Who invested in Celregen Therapeutics?
Celregen Therapeutics has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celregen Therapeutics raised?
Celregen Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Celregen Therapeutics last raise money?
Celregen Therapeutics's most recent round on record is a Angel, in Mar 2025.
What does Celregen Therapeutics do?
Established in 2022 and based in Hangzhou, China, Celregen Therapeutics is a medical service provider dedicated to the research and development and clinical transformation of regenerative medicine products such as cornea and pancreatic islets.
Where is Celregen Therapeutics headquartered?
Celregen Therapeutics is headquartered in Hangzhou, China.
Which VCs invest in companies like Celregen Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Celregen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Celregen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.